Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05854563 · ClinicalTrials.gov registry record

Cough Capture as a Portal Into the Lung

A clinical trial of Lung Cancer and Lung Diseases, sponsored by Albert Einstein College of Medicine.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT05854563 is a study of Lung Cancer and Lung Diseases that is actively recruiting participants, run by Albert Einstein College of Medicine. The registered enrollment target is 2,000 participants, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (115% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05854563, a study of Lung Cancer and Lung Diseases, is actively recruiting participants, sponsored by Albert Einstein College of Medicine.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

The lung is a privileged organ; blood does not reflect most lung processes well, if at all. Therefore, for population scale diagnostics, the investigator team is developing non-invasive portals to the lung, for eventual early detection/risk assessment and diagnostic purposes. However, large macromolecules are not likely suspended nor readily detected in the breath. In particular, genomic DNA in the breath condensate (EBC) is very sparse, and where present, generally highly fragmented, not readily amenable to sequencing based assessments of DNA somatic mutation burden or distribution. Because gDNA (and protein) is challenging to obtain non-invasively from EBC, the study team considered alternative surrogate lower airway specimens. Cough capture is rarely done, and the investigator team is in the process of optimizing its collection. Importantly, the team will be evaluating how much of coughed material is from saliva contamination. Additionally, analyzing material that is target captured by capturing deep lung extracellular vesicles (EVs) using immobilized CCSP/SFTPC antibodies targeting EVs from distal bronchiole Club and alveolar type 2 cells could circumvent the mouth contamination problem, leaving a non-invasive portal to the deep lung suitable for large molecules, and in turn suitable for myriad epidemiologic and clinical applications. The investigator team proposes (Aim 1) to pursue optimizing cough collection, and testing the efficacy and practicality of partitioning cough specimen for deep-lung specific extra-cellular vesicles (EVs). This cough specimen will be compared to that from invasively collected deep lung samples BAL/bronchial brushings, and to the potential contaminating mouth rinse, all from the same individuals. (Aim 2) The study team initially proposes to examine these cough specimens for somatic mutations by SMM bulk sequencing for single nucleotide variation, developed in the Vijg/Maslov labs. Finally, the investigator team will (Aim 3) test all

Interventions

  • OTHER Observational only, all subjects; measure DNA mutation and proteomic survey.

Study Locations (1)

New York

  • Albert Einstein College of Medicine - The Bronx

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2023-03-28
Est. Completion 2027-06

Sponsor

Albert Einstein College of Medicine

175 total trials

What the Registry Record Tells You About NCT05854563

The ClinicalTrials.gov registry entry for NCT05854563 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (115% higher). The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Observational only, all subjects; measure DNA mutation and proteomic survey. is the first listed.

NCT05854563 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05854563 about?

NCT05854563 is a clinical study titled "Cough Capture as a Portal Into the Lung". The lung is a privileged organ; blood does not reflect most lung processes well, if at all. Therefore, for population scale diagnostics, the investigator team is developing non-invasive portals to the lung, for eventual early detection/risk assessment and diagnostic purposes. However, large macromol...

What is the current status of trial NCT05854563?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2023-03-28. Estimated completion is 2027-06.

What conditions does trial NCT05854563 study?

This clinical trial studies the following conditions: Lung Cancer, Lung Diseases, Lung Diseases, Interstitial, Lung Diseases, Obstructive, Lung Inflammation.

What interventions are being tested in trial NCT05854563?

The interventions under investigation include: Observational only, all subjects; measure DNA mutation and proteomic survey. (OTHER).

Who is sponsoring clinical trial NCT05854563?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05854563 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.